206 related articles for article (PubMed ID: 229518)
21. Myasthenia gravis: a model disorder of acetylcholine receptors.
Drachman DB
Res Publ Assoc Res Nerv Ment Dis; 1987; 65():65-82. PubMed ID: 3330842
[No Abstract] [Full Text] [Related]
22. Humoral immunity in myasthenia gravis: relationship to disease severity and steroid treatment.
Bradley RJ; Dwyer D; Morley BJ; Robinson G; Kemp GE; Oh SJ
Prog Brain Res; 1979; 49():441-8. PubMed ID: 515441
[No Abstract] [Full Text] [Related]
23. Posttetanic potentiation in a patient with myasthenia gravis.
Singer P; Smith L; Ziegler DK; Festoff BW
Neurology; 1981 Oct; 31(10):1345-7. PubMed ID: 6287354
[TBL] [Abstract][Full Text] [Related]
24. Humoral immunity in myasthenia gravis: immunoglobulin class, affinity, and antigenic site.
Tindall RS
Trans Am Neurol Assoc; 1979; 104():16-8. PubMed ID: 553397
[No Abstract] [Full Text] [Related]
25. [Conceptual aspects of myasthenia gravis].
Ledro Molina D; Avilés Mejías S; Garrido Peralta M
Rev Clin Esp; 1981 Oct; 163(1):13-6. PubMed ID: 6276939
[No Abstract] [Full Text] [Related]
26. The role of acetylcholine receptor antibodies in myasthenia gravis.
Appel SH; Elias SB; Chauvin P
Fed Proc; 1979 Sep; 38(10):2381-5. PubMed ID: 478014
[TBL] [Abstract][Full Text] [Related]
27. Single-fiber electromyography during menstrual exacerbation and ovulatory suppression in MuSK antibody-positive myasthenia gravis.
Stickler DE; Stickler LL
Muscle Nerve; 2007 Jun; 35(6):808-11. PubMed ID: 17221882
[TBL] [Abstract][Full Text] [Related]
28. Acetylcholine nicotinic receptor: a key molecule for the pathogenesis of myasthenia gravis.
Sher E; Gotti C; Clementi F
Ann Ist Super Sanita; 1988; 24(1):103-16. PubMed ID: 3289434
[No Abstract] [Full Text] [Related]
29. Autoimmune myasthenia gravis in childhood.
Andrews PI
Semin Neurol; 2004 Mar; 24(1):101-10. PubMed ID: 15229797
[TBL] [Abstract][Full Text] [Related]
30. Cholinergic neuromuscular hyperactivity in patients with myasthenia gravis seropositive for MuSK antibody.
Punga AR; Flink R; Askmark H; Stålberg EV
Muscle Nerve; 2006 Jul; 34(1):111-5. PubMed ID: 16453324
[TBL] [Abstract][Full Text] [Related]
31. Insights in the autoimmunity of myasthenia gravis.
De Baets MH
Autoimmunity; 2010 Aug; 43(5-6):341-3. PubMed ID: 20380585
[TBL] [Abstract][Full Text] [Related]
32. Autoantibodies to acetylcholine receptors in myasthenia gravis.
N Engl J Med; 1983 Feb; 308(7):402-3. PubMed ID: 6823248
[No Abstract] [Full Text] [Related]
33. [Myasthenia gravis in newborn infants--pathological mechanism, clinical symptomatology and therapeutic procedures].
Krauze M; Musialik E; Swietliński J; Litwa K; Latko E; Górny J; Sobczyk J
Wiad Lek; 1992 Aug; 45(15-16):610-4. PubMed ID: 1488831
[TBL] [Abstract][Full Text] [Related]
34. Autoimmune disorders of neuromuscular transmission.
Mahadeva B; Phillips LH; Juel VC
Semin Neurol; 2008 Apr; 28(2):212-27. PubMed ID: 18351523
[TBL] [Abstract][Full Text] [Related]
35. Acquired canine myasthenia gravis: immunocytochemical localization of immune complexes at neuromuscular junctions.
Pflugfelder CM; Cardinet GH; Lutz H; Holliday TA; Hansen RJ
Muscle Nerve; 1981; 4(4):289-95. PubMed ID: 7019698
[TBL] [Abstract][Full Text] [Related]
36. Electrophysiological studies of thymectomized and nonthymectomized acetylcholine receptor-immunized animal models of myasthenia gravis.
Niemi WD; Nastuk WL; Chang HW; Penn AS; Rosenberry TL
Exp Neurol; 1979 Jan; 63(1):1-27. PubMed ID: 223859
[No Abstract] [Full Text] [Related]
37. Genetic and antibody-mediated channelopathies at the neuromuscular junction.
Vincent A; Mills K
Electroencephalogr Clin Neurophysiol Suppl; 1999; 50():250-8. PubMed ID: 10689470
[No Abstract] [Full Text] [Related]
38. Intravenous immune globulin in myasthenia gravis.
Gajdos P
Clin Exp Immunol; 1994 Jul; 97 Suppl 1(Suppl 1):49-51. PubMed ID: 8033435
[TBL] [Abstract][Full Text] [Related]
39. Pathophysiology of myasthenia gravis.
Hughes BW; Moro De Casillas ML; Kaminski HJ
Semin Neurol; 2004 Mar; 24(1):21-30. PubMed ID: 15229789
[TBL] [Abstract][Full Text] [Related]
40. [Acetylcholine receptor antibodies in myasthenia gravis].
Yakirevich V; Snir E; Brener T; Borenstein N; Vidne BA
Harefuah; 1983 Apr; 104(7):269-70. PubMed ID: 6618324
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
